Why We’re Doubling Down on pH7
With Series B funding, pH7 is poised to expand commercial production, refine and enter new verticals, and accelerate industry adoption of their closed-loop metals recovery platform. As partners and champions from the earliest days, Pangaea Ventures is thrilled to double down, investing alongside leaders who redefine what’s possible for clean industry and a healthier planet. Here’s why we’re doing it.
Pangaea Ventures Joins pH7’s $25.6 Million Series B
Pangaea Ventures is pleased to announce our participation in pH7 Technologies’ just-announced $25.6 million Series B financing, led by Fine Structure Ventures with participation from BHP Ventures, Energy & Environment Investment (EEI), Siteground, Gaingels, Calm Venture, and other existing investors
Membrion and Lam Research Announce Collaboration for Sustainable Water Treatment
Pangaea portfolio company Membrion and Lam Research, a global leader in semiconductor manufacturing solutions, have just announced their partnership to address expensive and critical environmental challenges in semiconductor manufacturing.
Why We Invested in Membrion
Pangaea’s investment in Membrion represents a convergence of advanced materials science, technical rigor, impact-driven innovation, and accelerating customer interest, the hallmarks of the companies we champion to drive planetary health.
Pangaea Ventures Highlights Semicon West Startup Social with Investment in Membrion’s $20M Series B1
Pangaea Ventures and the Arizona Commerce Authority hosted the Semicon West Startup Social during Semicon West’s first conference in Phoenix, a curated gathering of global semiconductor industry leaders highlighting Phoenix’s emergence as a vital node in the global semiconductor ecosystem.
Pangaea Ventures announces participation in Membrion’s $20 Million Series B1
Pangaea Ventures is pleased to announce our participation in Membrion’s $20 Million Series B1 funding, alongside PureTerra, Lam Research, Ecolab, W.L. Gore & Associates., and other existing investors.
Tidal Grow® Spectra™ Approved for Use on California Crops
Tidal Grow® Spectra™, developed by Tidal Grow, a division of Pangaea Ventures portfolio company Tidal Vision, has been approved for California specialty crops
Kanvas Biosciences Launches New GMP Lab to Unite Innovation and Scale in Microbiome Drug Development
Kanvas Biosciences has taken another leap forward with the announcement of their new Good Manufacturing Practices (GMP) facility in South San Francisco.
Aspect Biosystems Releases Preclinical Data Highlighting the Potential of Adrenal Bioprinted Tissue Therapeutics
Aspect Biosystems has released preclinical data highlighting the potential of their adrenal Bioprinted Tissue Therapeutics to restore adrenal function and treat primary adrenal insufficiency.
Vestaron’s SPEAR® LEP Bioinsecticide Granted Emergency Use Authorization to Protect High-Value Crops in Portugal
Vestaron has been granted emergency use approval in Portugal for its SPEAR® LEP bioinsecticide to protect high-value tomato crops from devastating pests.
AEPONYX Announces Acquisition by Global Quantum Computing Leader Pasqal
Pangaea Ventures is proud to share that AEPONYX, a Pangaea Ventures portfolio company, has been acquired by Pasqal, a global leader in quantum computing.
Pangaea Ventures Joins $18.7M Series A Investment in ChEmpower: Revolutionizing Semiconductor Manufacturing
We're excited to announce our participation in the oversubscribed $18.7M Series A financing for ChEmpower, a company that's pioneering a revolutionary approach to semiconductor manufacturing.
Kanvas Bio Publishes New Research on its Novel Spectral Imaging Platform, a Transformative Tool for Microbiome Drug Discovery and Development
Kanvas Biosciences, a Pangaea Ventures portfolio company, has published new research on its High-Phylogenetic-Resolution Spatial Mapping (HiPR-Map) Platform spectral imaging technology. This novel tool promises to transform how researchers visualize and analyze the complexities of the microbiome.
Portfolio Spotlight: NewLeaf Symbiotics - Pioneering PPFM Technology for a Sustainable Agricultural Future
Few companies in our portfolio exemplify Pangaea’s mission more clearly than NewLeaf Symbiotics, a pioneer in agricultural biotechnology that's revolutionizing the approach to sustainable farming.
Marsapet Launches First Dog Food Featuring FeedKind Pet Protein
Calysta and Marsapet have launched the first complete dog food featuring FeedKind Pet protein, a cultured protein fermented without using any arable land or animal ingredients.
ESS Global Fleet Achieves Operational Milestone Surpassing 2 GWh of Transacted Energy
ESS Tech, Inc. announced that the company’s global fleet of LDES solutions has transacted nearly 2.5 GWh of transacted energy
CarbonCure Reveals Groundbreaking Carbon Utilization Collaboration in Saudi Arabia with Abdin and Gulf Cryo
The multi-party collaboration will enable embodied carbon reductions at NEOM's large scale construction projects.
The Power Behind the Next Green Energy Revolution: Versogen
Green hydrogen could deliver 10% of required emissions reductions needed to reach net-zero by 2050, particularly in hard-to-decarbonize sectors like heavy industry and long-haul transport.
Why We Invested in Green Theme Technologies
Our decision to lead the Series C funding round for Green Theme Technologies' (GTT), a company making textile production more sustainable, underscores our commitment to breakthrough technologies that enable better, more sustainable outcomes for industry and the environment